Antwerp Cardiovascular Institute

The Antwerp Cardiovascular Institute (ACI), based at ZNA Middelheim in Antwerp, Belgium, is a world-renowned center for clinical research and advanced treatment in interventional cardiology. The institute is a leading global site for the development and testing of innovative cardiovascular technologies, including drug-eluting stents, bioresorbable scaffolds, and structural heart interventions. Led by prominent investigators such as Dr. Stefan Verheye, ACI has played a pivotal role in landmark clinical trials like DIVERGE and RRISC, which have shaped modern standards for treating complex coronary lesions. Beyond research, the institute provides high-volume, specialized clinical care, utilizing state-of-the-art imaging and minimally invasive techniques. ACI maintains strong collaborations with major medical device companies and academic institutions to translate scientific discoveries into clinical practice. Its expertise spans a wide range of indications, from refractory angina and heart failure to valvular heart disease.